title: Reply to J.M. Snaman et al.
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX dhui@mdanderson.org.
authors.forename: David
authors.initials: D
authors.lastname: Hui
authors.affiliation: University New Mexico Cancer Center, Albuquerque, NM.
authors.forename: Esmé
authors.initials: E
authors.lastname: Finlay
authors.affiliation: Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA.
authors.forename: Mary K
authors.initials: MK
authors.lastname: Buss
authors.affiliation: UCLA School of Medicine, Los Angeles, CA.
authors.forename: Eric
authors.initials: E
authors.lastname: Prommer
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Eduardo
authors.initials: E
authors.lastname: Bruera
mesh_terms: D000230:Adenocarcinoma / Q000628:therapy*; D005260:Female; D006801:Humans; D008495:Medical Oncology; D010166:Palliative Care; D010190:Pancreatic Neoplasms / Q000628:therapy*; D010361:Patients / Q000523:psychology*; D013038:Specialization